Recommendations on incurred sample stability (ISS) by GCC.

The topic of incurred sample stability (ISS) has generated considerable discussion within the bioanalytical community in recent years. The subject was an integral part of the seventh annual Workshop on Recent Issues in Bioanalysis (WRIB) held in Long Beach, CA, USA, in April 2013, and at the Global CRO Council for Bioanalysis (GCC) meeting preceding it. Discussion at both events focused on the use of incurred samples for ISS purposes in light of results from a recent GCC survey completed by member companies. This paper reports the consensus resulting from these discussions and serves as a useful reference for depicting ISS issues and concerns, summarizing the GCC survey results and providing helpful recommendations on ISS in the context of bioanalytical method development and application.

[1]  Roger Hayes,et al.  4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryover. , 2012, Bioanalysis.

[2]  Eileen Collins,et al.  Investigation and resolution of incurred sample reanalysis failures: two case studies. , 2011, Bioanalysis.

[3]  Fabio Garofolo,et al.  Conference report: the 3rd Global CRO Council for Bioanalysis at the International Reid Bioanalytical Forum. , 2011, Bioanalysis.

[4]  Fabio Garofolo,et al.  Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC). , 2012, Bioanalysis.

[5]  C. Sârbu,et al.  Incurred sample reanalysis: different evaluation approaches on data obtained for spironolactone and its active metabolite canrenone. , 2011, Bioanalysis.

[6]  Roger Hayes,et al.  Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis. , 2011, Bioanalysis.

[7]  Roger Hayes,et al.  Recommendations on biomarker bioanalytical method validation by GCC. , 2012, Bioanalysis.

[8]  Wenying Jian,et al.  Application of a stabilizer cocktail of N-ethylmaleimide and phenylmethanesulfonyl fluoride to concurrently stabilize the disulfide and ester containing compounds in a plasma LC-MS/MS assay. , 2014, Journal of pharmaceutical and biomedical analysis.

[9]  Stacy Ho,et al.  2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS. , 2013, Bioanalysis.

[10]  Roger Hayes,et al.  Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC). , 2012, Bioanalysis.

[11]  Xinping Fang,et al.  Formation of a Global Contract Research Organization Council for Bioanalysis. , 2010, Bioanalysis.

[12]  Roger Hayes,et al.  Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC). , 2012, Bioanalysis.

[13]  Roger Hayes,et al.  Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars. , 2012, Bioanalysis.